Cooperative pro-tumorigenic adaptation to oncogenic RAS through epithelial-to-mesenchymal plasticity - CRCL-Gastroentérologie et technologies pour la santé Accéder directement au contenu
Article Dans Une Revue Science Advances Année : 2024

Cooperative pro-tumorigenic adaptation to oncogenic RAS through epithelial-to-mesenchymal plasticity

Frédérique Fauvet
Roxane Pommier
Christelle Lamblot
Rahma Benhassoun
Francesca Angileri
Anne-Pierre Morel

Résumé

In breast cancers, aberrant activation of the RAS/MAPK pathway is strongly associated with mesenchymal features and stemness traits, suggesting an interplay between this mitogenic signaling pathway and epithelial-tomesenchymal plasticity (EMP). By using inducible models of human mammary epithelial cells, we demonstrate herein that the oncogenic activation of RAS promotes ZEB1-dependent EMP, which is necessary for malignant transformation. Notably, EMP is triggered by the secretion of pro-inflammatory cytokines from neighboring RASactivated senescent cells, with a prominent role for IL-6 and IL-1α. Our data contrast with the common view of cellular senescence as a tumor-suppressive mechanism and EMP as a process promoting late stages of tumor progression in response to signals from the tumor microenvironment. We highlighted here a pro-tumorigenic cooperation of RAS-activated mammary epithelial cells, which leverages on oncogene-induced senescence and EMP to trigger cellular reprogramming and malignant transformation.
Fichier principal
Vignette du fichier
sciadv.adi1736.pdf (3.01 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
licence

Dates et versions

hal-04459389 , version 1 (15-02-2024)

Licence

Identifiants

Citer

Hadrien de Blander, Laurie Tonon, Frédérique Fauvet, Roxane Pommier, Christelle Lamblot, et al.. Cooperative pro-tumorigenic adaptation to oncogenic RAS through epithelial-to-mesenchymal plasticity. Science Advances , 2024, 10 (7), ⟨10.1126/sciadv.adi1736⟩. ⟨hal-04459389⟩
35 Consultations
30 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More